Evidence map›Paper›PMID 26993982›Full record

ArticleLifetime data analysis2017

Generalized accelerated failure time spatial frailty model for arbitrarily censored data.

Haiming Zhou, Timothy Hanson, Jiajia Zhang

Abstract read
In one paragraph

Article in Lifetime data analysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Haiming ZhouDivision of Statistics, Northern Illinois University, DeKalb, IL, 60115, USA. zhouh@niu.edu.
Timothy HansonDepartment of Statistics, University of South Carolina, Columbia, SC, 29208, USA.
Jiajia ZhangDepartment of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC, 29208, USA.

Funding

Innovative Spatio-temporal Survival Models Allowing Crossing SurvivalR03CA176739 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI HANSON, TIMOTHY E., ZHANG, JIAJIA · 2014 to 2015
$142k
NCI NIH HHS R03 CA176739
6 · The paper itself

Abstract

Flexible incorporation of both geographical patterning and risk effects in cancer survival models is becoming increasingly important, due in part to the recent availability of large cancer registries. Most spatial survival models stochastically order survival curves from different subpopulations. However, it is common for survival curves from two subpopulations to cross in epidemiological cancer studies and thus interpretable standard survival models can not be used without some modification. Common fixes are the inclusion of time-varying regression effects in the proportional hazards model or fully nonparametric modeling, either of which destroys any easy interpretability from the fitted model. To address this issue, we develop a generalized accelerated failure time model which allows stratification on continuous or categorical covariates, as well as providing per-variable tests for whether stratification is necessary via novel approximate Bayes factors. The model is interpretable in terms of how median survival changes and is able to capture crossing survival curves in the presence of spatial correlation. A detailed Markov chain Monte Carlo algorithm is presented for posterior inference and a freely available function frailtyGAFT is provided to fit the model in the R package spBayesSurv. We apply our approach to a subset of the prostate cancer data gathered for Louisiana by the surveillance, epidemiology, and end results program of the National Cancer Institute.

Indexed as

Models, StatisticalMonte Carlo MethodSurvival AnalysisBayes TheoremHumansMaleMarkov ChainsProstatic NeoplasmsHeteroscedastic survivalInterval-censored dataLinear dependent tailfree processSpatial dataStratified AFT model

Identifiers

PMID26993982
PMCPMC5352560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.